Tilray Brands (NASDAQ:TLRY) Upgraded to “Strong-Buy” at TD Securities

TD Securities upgraded shares of Tilray Brands (NASDAQ:TLRYFree Report) to a strong-buy rating in a report published on Friday,Zacks.com reports.

A number of other equities research analysts have also recently weighed in on the stock. TD Cowen cut their price objective on shares of Tilray Brands from $7.00 to $5.00 and set a “buy” rating on the stock in a report on Tuesday, July 14th. Wall Street Zen cut Tilray Brands from a “hold” rating to a “sell” rating in a research report on Saturday. Weiss Ratings lowered Tilray Brands from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, May 13th. ATB Cormark Capital Markets lowered their price objective on Tilray Brands from $9.50 to $9.00 and set a “sector perform” rating for the company in a research note on Thursday, April 2nd. Finally, Roth Capital upgraded Tilray Brands from a “neutral” rating to a “buy” rating and set a $10.00 price target for the company in a report on Thursday, April 2nd. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, three have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, Tilray Brands has a consensus rating of “Moderate Buy” and an average price target of $11.00.

Check Out Our Latest Stock Analysis on Tilray Brands

Tilray Brands Stock Performance

Shares of Tilray Brands stock opened at $4.54 on Friday. Tilray Brands has a 12 month low of $3.67 and a 12 month high of $23.20. The firm has a market capitalization of $529.14 million, a P/E ratio of -4.20 and a beta of 1.89. The company has a current ratio of 2.21, a quick ratio of 1.66 and a debt-to-equity ratio of 0.22. The business has a fifty day simple moving average of $4.67 and a two-hundred day simple moving average of $6.26.

Tilray Brands (NASDAQ:TLRYGet Free Report) last issued its quarterly earnings results on Tuesday, July 28th. The company reported ($0.43) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.42). Tilray Brands had a negative return on equity of 7.76% and a negative net margin of 13.11%.The business had revenue of $281.71 million during the quarter, compared to the consensus estimate of $246.30 million. On average, equities analysts forecast that Tilray Brands will post -0.34 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of TLRY. Hilton Head Capital Partners LLC bought a new position in shares of Tilray Brands in the fourth quarter worth about $38,000. Pictet Asset Management Holding SA grew its stake in shares of Tilray Brands by 38.9% during the 1st quarter. Pictet Asset Management Holding SA now owns 18,387 shares of the company’s stock valued at $119,000 after acquiring an additional 5,145 shares during the period. Schonfeld Strategic Advisors LLC increased its holdings in Tilray Brands by 4.5% in the 4th quarter. Schonfeld Strategic Advisors LLC now owns 144,358 shares of the company’s stock worth $1,304,000 after acquiring an additional 6,182 shares in the last quarter. Baader Bank Aktiengesellschaft increased its holdings in Tilray Brands by 17.7% in the 1st quarter. Baader Bank Aktiengesellschaft now owns 47,938 shares of the company’s stock worth $293,000 after acquiring an additional 7,226 shares in the last quarter. Finally, IFP Advisors Inc raised its stake in Tilray Brands by 14.3% during the 4th quarter. IFP Advisors Inc now owns 60,318 shares of the company’s stock worth $545,000 after acquiring an additional 7,541 shares during the period. Hedge funds and other institutional investors own 9.35% of the company’s stock.

Key Stories Impacting Tilray Brands

Here are the key news stories impacting Tilray Brands this week:

  • Positive Sentiment: Unusual options activity provided a bullish trading signal: investors purchased 23,521 TLRY call options, approximately 82% above the stock’s typical daily call volume. This suggests increased speculative interest in further gains.
  • Positive Sentiment: Jefferies reiterated its Buy rating, saying Tilray is making progress in its transition toward a diversified consumer-products company. The firm’s view supports the potential for longer-term value from Tilray’s cannabis, beverage and other businesses. Tilray Brands seen creating long-term value through diversified platform, Jefferies says
  • Neutral Sentiment: Southern Glazer’s Wine & Spirits completed its acquisition of substantially all of Eagle Rock Distributing’s Colorado assets. The transaction could be relevant to Tilray’s beverage-distribution strategy if it affects industry relationships, but the announcement did not directly identify Tilray or quantify an impact on its results. Southern Glazer’s Wine & Spirits Closes Acquisition of Eagle Rock Distributing Co.
  • Negative Sentiment: Jefferies lowered its price target to $19 and reduced fiscal 2027 and 2028 EBITDA estimates after Tilray’s guidance for fiscal 2027 adjusted EBITDA of $68 million to $75 million came in below the roughly $84 million consensus estimate. The lower forecasts highlight continuing profitability concerns.
  • Negative Sentiment: Tilray remains in a prolonged downtrend, having lost substantial value this year alongside other cannabis stocks. Its weak recent momentum and history of quarterly losses remain risks despite the current rebound. Tilray Brands stock continues its downward spiral

Tilray Brands Company Profile

(Get Free Report)

Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.

Tilray’s product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.

Featured Articles

Analyst Recommendations for Tilray Brands (NASDAQ:TLRY)

Receive News & Ratings for Tilray Brands Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray Brands and related companies with MarketBeat.com's FREE daily email newsletter.